» Articles » PMID: 11337370

Nephrin Redistribution on Podocytes is a Potential Mechanism for Proteinuria in Patients with Primary Acquired Nephrotic Syndrome

Overview
Journal Am J Pathol
Publisher Elsevier
Specialty Pathology
Date 2001 May 5
PMID 11337370
Citations 79
Authors
Affiliations
Soon will be listed here.
Abstract

We investigated the distribution of nephrin by immunofluorescence microscopy in renal biopsies of patients with nephrotic syndrome: 13 with membranous glomerulonephritis (GN), 10 with minimal change GN, and seven with focal segmental glomerulosclerosis. As control, six patients with IgA GN without nephrotic syndrome and 10 normal controls were studied. We found an extensive loss of staining for nephrin and a shift from a podocyte-staining pattern to a granular pattern in patients with nephrotic syndrome, irrespective of the primary disease. In membranous GN, nephrin was co-localized with IgG immune deposits. In the attempt to explain these results, we investigated in vitro whether stimuli acting on the cell cytoskeleton, known to be involved in the pathogenesis of GN, may induce redistribution of nephrin on the surface of human cultured podocytes. Aggregated but not disaggregated human IgG(4), plasmalemmal insertion of membrane attack complex of complement, tumor necrosis factor-alpha, and puromycin, induced the shedding of nephrin with a loss of surface expression. This phenomenon was abrogated by cytochalasin and sodium azide. These results suggest that the activation of cell cytoskeleton may modify surface expression of nephrin allowing a dislocation from plasma membrane to an extracellular site.

Citing Articles

miR-204-5p Protects Nephrin from Enzymatic Degradation in Cultured Mouse Podocytes Treated with Nephrotoxic Serum.

Haddad G, Blaine J Cells. 2025; 14(5).

PMID: 40072092 PMC: 11899291. DOI: 10.3390/cells14050364.


Anti-nephrin antibody: a potential biomarker of minimal change disease.

Chen Q, Chen S, Ye Q, Lin W, Liao Y, Xiong Y Clin Kidney J. 2025; 18(3):sfaf012.

PMID: 40046822 PMC: 11879414. DOI: 10.1093/ckj/sfaf012.


SA4503 Mitigates Adriamycin-Induced Nephropathy via Sigma-1 Receptor in Animal and Cell-Based Models.

Tagashira H, Chida S, Bhuiyan M, Fukunaga K, Numata T Pharmaceuticals (Basel). 2025; 18(2).

PMID: 40005987 PMC: 11858467. DOI: 10.3390/ph18020172.


Detailed Pathophysiology of Minimal Change Disease: Insights into Podocyte Dysfunction, Immune Dysregulation, and Genetic Susceptibility.

Roman M, Nowicki M Int J Mol Sci. 2024; 25(22).

PMID: 39596249 PMC: 11595011. DOI: 10.3390/ijms252212174.


Mechanisms that potentially contribute to the development of post-streptococcal glomerulonephritis.

Munif M, Hart R, Rafeek R, Mallawaarachchi A, Anderson L, McMillan D Pathog Dis. 2024; 82.

PMID: 39341789 PMC: 11556339. DOI: 10.1093/femspd/ftae024.


References
1.
Delarue F, Virone A, Hagege J, Lacave R, Peraldi M, Adida C . Stable cell line of T-SV40 immortalized human glomerular visceral epithelial cells. Kidney Int. 1991; 40(5):906-12. DOI: 10.1038/ki.1991.292. View

2.
Camussi G, Kerjaschki D, Gonda M, Nevins T, Rielle J, Brentjens J . Expression and modulation of surface antigens in cultured rat glomerular visceral epithelial cells. J Histochem Cytochem. 1989; 37(11):1675-87. DOI: 10.1177/37.11.2809176. View

3.
Coers W, Huitema S, van der Horst M, Weening J . Puromycin aminonucleoside and adriamycin disturb cytoskeletal and extracellular matrix protein organization, but not protein synthesis of cultured glomerular epithelial cells. Exp Nephrol. 1994; 2(1):40-50. View

4.
Moutabarrik A, Nakanishi I, Zaid D, Namiki M, Kawaguchi N, Onishi S . Interleukin-1-beta activation of cultured glomerular epithelial cells. Exp Nephrol. 1994; 2(3):196-204. View

5.
Brizzi M, Aronica M, Rosso A, Bagnara G, Yarden Y, Pegoraro L . Granulocyte-macrophage colony-stimulating factor stimulates JAK2 signaling pathway and rapidly activates p93fes, STAT1 p91, and STAT3 p92 in polymorphonuclear leukocytes. J Biol Chem. 1996; 271(7):3562-7. DOI: 10.1074/jbc.271.7.3562. View